Literature DB >> 25626331

Acute hepatitis in a child heterozygous for the I259V MEFV gene variant.

Flora Tzifi1, Philip Hawkins2, Erato Atsali1, Doxa Kotzia1, Achilleas Attilakos1.   

Abstract

Familial Mediterranean Fever (FMF) is a systemic auto-inflammatory disease characterized by recurrent episodes of fever accompanied by synovial, serosal and/or cutaneous inflammation. Liver involvement has been described mainly in patients with paired FMF gene mutations, i.e. involving both alleles, and rarely in patients heterozygous for FMF mutations. These patients may present with acute or chronic hepatitis, with or without liver failure. Non-alcoholic hepatitis, mild hyperbilirubinemia, and elevation of liver enzymes of unknown etiology should also raise suspicion of FMF. Patients with FMF and liver involvement usually respond to colchicine medication. The mutation I259V (c.775A MEFV gene has not been reported in FMF patients with liver involvement. Furthermore, among several MEFV gene variants, it has been reported so far in only one heterozygous FMF patient of Turkish ancestry presenting with abdominal pain without any hepatic complication. Herein, the second case of a FMF patient heterozygous for the above mentioned mutation is discussed. It is a male child with FMF clinical phenotype which presented two consecutively episodes of acute hepatitis during fever attacks, that spontaneously resolved. Therapeutic trial with colchicine was successful, since no other fever attacks and acute hepatitis episodes were noticed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25626331     DOI: 10.14712/23362936.2014.43

Source DB:  PubMed          Journal:  Prague Med Rep        ISSN: 1214-6994


  2 in total

1.  Severe liver involvement in two patients with long-term history of fever: remember familial Mediterranean fever.

Authors:  Nikolaos K Gatselis; Panagiotis Skendros; Konstantinos Ritis; George N Dalekos
Journal:  BMJ Case Rep       Date:  2016-09-22

2.  Familial Mediterranean Fever: an unusual cause of liver disease.

Authors:  Maria Cristina Maggio; Maria Castiglia; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2019-09-18       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.